Table 2 Challenges in conducting therapeutic trials in Wegener's granulomatosis

Rarity of Wegener's granulomatosis

Potential for active disease to be life threatening

Available treatment of established efficacy

Definition of outcome measures

Imprecise means of assessing active disease

Extended follow-up is necessary to fully assess relapse and to reach study endpoints